Form 485BPOS PRUCO LIFE FLEXIBLE PREM
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20240404/AH22T22CY222C2Z222252WYZA52SE2G2X262
Filed on: April 4, 2024
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients Aged 6 Years and Older
- Vector Science & Therapeutics Reports First Quarterly Financial Results as a Public Company; Announces Inaugural Investor Q&A on July 28
- Oportun Named to the CNBC World’s Top Fintech Companies 2026 List for Third Consecutive Year
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
